Showing results (331-340 of 422) with videos related to
Sort By:
Pageof 43
HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.Journal of Clinical Epidemiology|July 20, 2020
Replication Research Series-Paper 1 : A concept analysis and meta-narrative review established a comprehensive theoretical definition of replication research to improve its useBrigitte Vachon, Janet A Curran, Sathya Karunananthan, et al.BMJ Open|March 19, 2022
Identifying children with medical complexity in administrative datasets in a Canadian context: study protocolHolly McCulloch, Sydney Breneol, Samuel A Stewart, et al.International Journal of Nursing Studies Advances|July 2, 2025
Co-designing interventions to improve emergency department discharge communication with youths, parents and healthcare providers: a process evaluationAllyson J Gallant, Janet A Curran, Mari Somerville, et al.The Journal of Antimicrobial Chemotherapy|August 9, 2007
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patientsI Molina, V Falcó, M Crespo, et al.HIV Medicine|January 10, 2013
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB studyE Ribera, M Larrousse, A Curran, et al.HIV Medicine|December 16, 2014
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratioE Martínez, E Ribera, B Clotet, et al.HIV Medicine|June 4, 2009
Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal diseaseA Imaz, V Falcó, M Peñaranda, et al.Scientific Reports|April 4, 2026
IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancerAkash R Boda, Irfan N Bandey, Saikat Chowdhury, et al.Cancer Immunology Research|December 8, 2016
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 BlockadeShane A Curran, Justin A Shyer, Erin T St Angelo, et al.Pageof 43